000566 Hainan Haiyao
WatchlistHainan Haiyao News
Hainan Haiyao Unit Receives 1.2 Million Yuan Government Subsidy
Hainan Haiyao (SHE:000566) has received 1.2 million yuan in government subsidy from the local government of Haikou City in China's Hainan province. The subsidy was issued in relation to the company's
Hainan Haiyao Unit's Minocycline Hydrochloride Capsules Passes Drug Regulator's Evaluation
04:55 AM EST, 03/08/2023 (MT Newswires) -- Haikou Pharmaceutical Factory, a unit of Hainan Haiyao (SHE:000566), received notification that minocycline hydrochloride capsules passed the consistency eva
Hainan Haiyao Unit Gets Regulatory Nod for Antibacterial Drug
02:33 AM EST, 01/31/2023 (MT Newswires) -- Haikou Pharmaceutical Factory, a subsidiary of Hainan Haiyao (SHE:000566), received approval from China's National Medical Products Administration for its ce
Hainan Haiyao Gets Regulatory Nod for Anti-Skin Disease Drug
05:12 AM EST, 01/09/2023 (MT Newswires) -- Hainan Haiyao (SHE:000566) unit Haikou Pharmaceutical Factory obtained regulatory approval for the registration of desloratadine oral solution drug. The drug
Sector changes | The API industry ushered in sector-based investment opportunities, and changes in pharmaceutical stocks rose
The Zhitong Finance App learned that on November 10, due to news that the API industry ushered in sector-based investment opportunities, A-share pharmaceutical stocks fluctuated and rose. As of press release, Tuoxin Pharmaceutical (301089.SZ) rose more than 13%; Hainan Pharmaceutical (000566.SZ) rose and stopped; Fengyuan Pharmaceutical (000153.SZ), Hengrui Pharmaceutical (600276.SH), Hanyu Pharmaceutical (300199.SZ), Kangyuan Pharmaceutical (600557.SH) and other stocks rose. On November 9, according to the NDRC website, the National Development and Reform Commission and the Ministry of Industry and Information Technology issued “On Promoting High Quality in the API Industry
Hainan Haiyao Receives Letter of Concern: Request for Explanation of Specific Reasons for Higher Financial Expenses
Gelonhui, July 23 丨 Hainan Haiyao received a letter of concern. The exchange requested the company to explain the specific reasons for maintaining a high debt scale and bearing higher financial expenses when a large amount of money was retained on the books and there was no significant increase in operating income.
News flash: Hainan Haiyao dropped to 9.92 yuan and stopped reporting
Financial website, July 16 — Today, Hainan Haiyao opened at 10.97 yuan, ending at 09:35. The stock fell 9.98% to 9.92 yuan, ending at 9.95 yuan, ending the decline. Yesterday (2020/7-15), the stock had a net inflow of 688 million yuan, a net inflow of main players of 658 million yuan, a net inflow of 12.324,800 yuan from Chinese orders, and a net inflow of 18.264,800 yuan from retail investors. In the last month, Hainan Haiyao has been on the Dragon Tiger list a total of 2 times, indicating that Hainan Haiyao's stock is average. The company is mainly engaged in the import and export of proprietary Chinese and Western medicines, fine chemical products, chemical raw materials, health products, and those supporting the pharmaceutical industry
Analysis of strong sectors on the 15th: The hotel and catering sector rose sharply, and food and beverage stocks were active
On July 15, the stock indexes of the two markets maintained a weak and volatile trend in the intraday period. At the close, the Shanghai Index fell 1.56% to 3361.3 points, the Shenzhen Index fell 1.87% to 13734.13 points, and the GEM Index fell 1.6% to 2813.06 points. Looking at the market, the tourism, hotel and catering sectors have risen sharply, alcohol stocks have once again become active, and the food, beverage, and pharmaceutical sectors have strengthened. Specifically, the hotel, travel, hotel, food and tourism sectors have risen sharply intraday today. By the close, Hualin Tourism, Qujiang Cultural Tourism, Changbai Mountain, Yunnan Tourism, Xi'an Tourism, Zhangjiajie, Jiuhua Tourism, Dalian Shengya, Tianmu Lake, Huangshan Travel
Pharmaceutical stocks strengthened, Hainan Haiyao, Hepui, etc. rose and stopped
According to e-company news, pharmaceutical stocks strengthened, and Jiudian Pharmaceutical, Hainan Haiyao, and Hepuri rose and stopped, while the Tibetan pharmaceutical industry rose more than 9%.
Rise, stop, resume trading | Predictive performance increases, and pharmaceutical stocks are still divided collectively
(Market description) The two markets adjusted today. Near the end of the session, the index rebounded. Individual stocks in the two markets diverged, and nearly 20 stocks fell to a standstill. The short-term mood in the market was poor, and the willingness to sell in profit markets was strong. In terms of the sector, high-ranking sectors weakened sharply. The tax-free and semiconductor sectors once led the decline. Many high-ranking stocks such as Caesar Travel, Zhende Healthcare, and Guangbai Co., Ltd. fell to a standstill. In the afternoon, core stocks such as Huatian Technology and Shanghai Silicon Industry led a rebound in the semiconductor sector. The GEM index rebounded, and sectors such as agricultural cultivation, water conservancy, brokerage firms, coal and other sectors rose one after another. Looking at the overall situation, the return to high profit markets put a lot of pressure on the market, but market carrying performance was strong, and capital rotated rapidly.
Afternoon Review|Collective Index Adjustment Market Earning Effect Declines, Net Outflow of Main Capital of 78 billion dollars
On Tuesday, the stock indexes of the two markets fell collectively, the Shanghai index fell back to 3,400 points, and the GEM index fell below the 5-day EMA. By the midday closing, the Shanghai Index reported 3405.30 points, a decrease of 1.10%, the Shenzhen Index reported 13911.49 points, a decrease of 1.68%, and the GEM index reported 2832.87 points, a decrease of 1.96%. The two markets traded a total of 1082.9 billion yuan in the morning, an increase of 96.4 billion yuan over the same period yesterday. There was a net outflow of capital from Northbound Capital of 11.395 billion yuan in half a day, including a net outflow of 3.488 billion yuan from Shanghai Stock Connect and a net outflow of 7.907 billion yuan from Shenzhen Stock Connect. In terms of sectors, the increase in the bus, defense, military, and biological products sectors depended on
Analysis of the strong sector on the 13th: the agricultural sector broke out, and the hydraulic construction sector rose sharply
On July 13, the Shanghai Index opened slightly lower. Following the rebound in financial stocks in the intraday market, it surged nearly 2% to 3,450 points in the afternoon. The Shenzhen Index and GEM Index maintained a strong upward trend. By the close, the Shanghai Index rose 1.77% to 3443.29 points, the Shenzhen Index rose 3.5% to 14149.14 points, and the GEM Index rose 3.99 to 2889.43 points. The two markets traded a total of $1.67 trillion. Looking at the market, the agricultural sector exploded, the water conservancy construction sector rose sharply, and the food, beverage, and pharmaceutical sectors showed strong trends. Specifically: 1. In the agricultural sector, the agricultural sector exploded intraday today. The seed industry and pork stock tables
Rise, stop and resume trading | Agricultural planting has sharply boosted performance, and the sector has collectively risen
(Market description) The GEM index continues to be tight, market sentiment is excited, individual stocks are generally rising, more than 200 shares have risen and stopped, and the monetization effect continues to increase. In terms of the sector, there was a clear shift in the strong sectors in the early stages. Brokers and duty-free firms were sharply divided. Catalyzed by weekend news, sectors such as agriculture, water conservancy, non-ferrous materials, pharmaceuticals and medical care rose sharply. In the afternoon, the lithium battery and semiconductor sectors strengthened, and high-ranking stocks in the market such as Xinghui Precision, Bailian Co., Ltd. and Guangdong Ganhua fell sharply, but the market's capital carrying capacity was strong. Looking at the market, individual stock companies such as China Airlines Shen Fei have rebounded steadily. Looking at the overall market, there was a sharp decline in high-ranking stocks and large capital losses in the market. Healthy rotation, low position and in
News flash: Hainan Haiyao stopped reporting at 9.11 yuan
Financial website, July 13 — Today, Hainan Haiyao opened at 8.32 yuan, ending at 10:15. The stock rose 10.02% to 9.11 yuan, ending at 10:15, ending the rise. Yesterday (2020/7-10), the stock had a net inflow of RMB 22.901 million, a net inflow of the main force of RMB 276.884 million, a net outflow of RMB 1,328,400 from domestic orders, and a net outflow of 3,570,900 yuan from retail investors. In the last month, Hainan Haiyao has been on the Dragon Tiger list 0 times, indicating that Hainan Haiyao's stock is not active. The company is mainly engaged in proprietary Chinese and Western pharmaceuticals, fine chemical products, chemical raw materials, health products, and pharmaceutical industries
Hainan Haiyao (000566.SZ)'s semi-annual net profit is expected to drop 26%-51%
Glonhui July 10丨Hainan Haiyao (000566.SZ) announced that it expects net profit attributable to shareholders of listed companies in the first half of 2020 to 40 million yuan to 60 million yuan, a year-on-year decrease of 26%-51%. The main reasons for the change in performance are as follows: 1. In the first quarter of 2020, due to the impact of the COVID-19 epidemic, the resumption of work and production by the company and customers was delayed; the prices of the APIs and intermediates required by the company to produce rose sharply, leading to a rise in production costs; hospitals across the country provided medical services and patient visits were all affected to varying degrees, and demand for pharmaceutical terminals fell seriously, leading to a serious decline in the company's product business
Hainan Haiyao: The subsidiary's small RNA silencing technology design was applied for the first time at home and abroad
Hainan Haiyao (000566) said on an interactive platform that the company's subsidiary Shanghai Youcadi Biomedical Technology Co., Ltd. submitted more than 30 invention patents related to CAR-T technology, ranking first among domestic peers, and upgraded CAR-T technology and developed multiple products. A small RNA silencing technology for interleukin 6 was designed on the CAR carrier, while not affecting clinical treatment results, reducing the risk caused by the cytokine storm. This design was applied for the first time at home and abroad. The related products completed hundreds of clinical research cases of CAR-T for hematologic tumors, and achieved excellent results. The expected effect.
The Hainan sector has risen across the board, and the overall plan for the construction of the Hainan Free Trade Port has been implemented
Gelonghui, June 2 | The Hainan A-share sector rose across the board. Among them, Hyde shares, Dadonghai A, and Huawen Group rose and stopped, and intercontinental oil and gas came to a stop. Kangzhi Pharmaceutical, Hainan Haiyao, Beijing Liangliang Holdings, Shuangcheng Pharmaceutical, Haiqi Group, Luo Niushan, etc. all rose markedly. The Central Committee of the Communist Party of China and the State Council issued the “Overall Plan for the Construction of the Hainan Free Trade Port”, which proposes vigorously developing tourism, modern services and high-tech industries, continuously consolidating the foundation of the real economy and enhancing the competitiveness of the industry. By 2025, a free trade port policy system focusing on free trade facilitation and investment freedom and facilitation will be initially established. CITIC Securities
The overall plan for the Hainan Free Trade Port has been implemented, and the Hainan sector has collectively surged
Sina Financial News reported on June 2 that the Hainan sector has collectively surged. As of press release, Hyde Co., Ltd., Huawen Group, and Dadonghai A have risen and stopped, while Intercontinental Oil & Gas, Hainan Ruize, Hainan Haiyao, and Luo Niushan have collectively opened higher. According to the news, according to the news, the Central Committee of the Communist Party of China and the State Council issued the “Overall Plan for the Construction of the Hainan Free Trade Port”, which covers the entire island of Hainan Island. The goal is to initially establish a free trade port policy system focusing on free and convenient trade and free and convenient investment by 2025; by 2035, free and convenient trade, free and convenient investment, free and convenient cross-border capital flows, and free and convenient entry and exit of people,
海南海药(000566.SZ)获准注册15亿元中期票据
格隆汇5月19日丨海南海药(000566.SZ)公布，公司于近日收到交易商协会的《接受注册通知书》(中市协注〔2020〕MTN545号)。公司中期票据注册金额为15亿元，注册额度自本通知书落款之日起2年内有效，由渤海银行主承销。
Hainan Haiyao (000566.SZ) plans to accept loans of 150 million yuan from related parties
Gelonhui May 15 丨 Hainan Haiyao (000566.SZ) announced that according to the company's capital requirements and future development strategy needs, the company plans to accept Xinxing Jihua Pharmaceutical Holdings Co., Ltd. (“Huatong Industrial”), the controlling shareholder of the controlling shareholder Hainan Huatong Industrial Co., Ltd. (“Huatong Industrial”), a holding subsidiary of Xinxing Jihua Pharmaceutical Holdings Co., Ltd. (“Pharmaceutical Holdings”), a holding subsidiary of Beijing Kaizheng Biotechnology Development Co., Ltd. (“Kaizheng Biotech”), provided a loan of 150 million yuan to the company for a period of 1 year. Within the above loan amount, the funds can be used on a rolling basis. The annualized interest rate for the loan can be used on a rolling basis, according to 5% of the actual usage amount and actual usage amount Measured in days To receive it, the company does not need this money